Home Alternative Medizin Bisse und Stiche Krebs AGB-Behandlungen Zahngesundheit Diät und Ernährung Familiengesundheit Gesundheitsindustrie
|  | Gesundheitswissenschaften >  | Krebs | Bestrahlung

Chemotherapie und Strahlentherapie: Hauptnebenwirkungen und Management-Prinzipien

Both modalities target rapidly dividing cells, causing on‑target toxicity in normal tissues. Understanding common side effects enables proactive management.

Chemotherapy: Systemic Toxicities

Organ SystemKey EffectsMonitoring/Mitigation
HematologicNeutropenia, anemia, thrombocytopeniaCBC q cycle; G‑CSF for febrile neutropenia risk
GINausea/vomiting (acute/delayed), mucositis, diarrhea5‑HT3/NK1/dexamethasone prophylaxis; oral care
DermatologicAlopecia, hand‑foot syndrome, rash, nail changesScalp cooling (alopecia); urea creams (HFS)
RenalTubular toxicity (cisplatin), hemorrhagic cystitis (cyclophosphamide)Hydration, mesna, dose adjustment
HepaticSinusoidal obstruction, steatohepatitisLFTs monitoring
CardiacAnthracycline cardiomyopathy, 5‑FU ischemiaEcho/MUGA baseline/serial; dexrazoxane
PulmonaryBleomycin pneumonitis/fibrosisPFTs; avoid high O₂
NeurologicPeripheral neuropathy (platinums, taxanes, vinca)Dose reduction; duloxetine for CIPN
ReproductiveGonadal failure, infertilityFertility preservation counseling pre‑treatment
Secondary malignancyAML/MDS (alkylators, topo II inhibitors), solid tumorsLong‑term survivorship screening

Radiation Therapy: Local/Regional Toxicities

SiteAcuteLate
SkinErythema, desquamationFibrosis, telangiectasia, pigment change
MucosaMucositis, dysphagia, proctitisStricture, fistula, atrophy
Organ‑specificPneumonitis (lung), cystitis (bladder), enteritis (bowel)Fibrosis, secondary cancer, vascular injury
SystemicFatigue (universal)—

Shared Principles

  • Pre‑treatment baseline assessment (organ function, fertility, psychosocial).
  • Multidisciplinary supportive care (palliative, nutrition, rehab, psycho‑oncology).
  • Survivorship care plans documenting exposures and surveillance schedules.

Individual risk varies by regimen, dose, volume, age, comorbidities, and genetics. Oncology teams tailor prophylaxis and surveillance accordingly.

logo

www.alskrankheit.net © Gesundheitswissenschaften